In a step toward disease-modifying therapy, Tufts researchers and collaborators have pioneered nanoparticles that target damaged cartilage and adapt to disease severity.
Laura Baecher-Lind will serve on the editorial board of the journal Academic Medicine, extending Tufts’ impact on national conversations in medical education.